AIFA approves the booster dose with the Comirnaty vaccine for the age group 12-15 years

The Technical Scientific Commission (CTS) of AIFA, in the extraordinary session yesterday, 5 January 2022, at the request of the Ministry of Health, expressed its favorable opinion on the possibility of providing a vaccine booster dose also for subjects aged between 12 and 15 years old. In analogy with what has already been established for the age group 16-17 years and for frail subjects of 12-15 years, this booster must be carried out with the Comirnaty vaccine.

As regards the interval between the primary vaccination course and the administration of the booster dose, in the absence of specific data for this age group, the CTS considers it reasonable to maintain the same criteria adopted in adults. As in any other case, the efficacy and safety data relating to this further expansion will be subject to constant monitoring.

Finally, it is reiterated that the primary objective of the vaccination campaign remains the completion of the primary vaccination cycle for the entire eligible population.

AIFA approves the booster dose with the Comirnaty vaccine for the age group 12-15 years

| NEWS ', EVIDENCE 4 |